FOXP3 and colitis: In a mouse model of distal colitis (16), we found that administration of an LAP-depleting antibody that has no effect on the frequency of CD4+Foxp3+ Tregs (17) was associated with the development of extensive colitis, suggesting that CD3+CD4+LAP+Foxp3-regulatory cells limit the extension of inflammatory lesions in UC.